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A B S T R A C T
X-linked Adrenoleukodystrophy (X-ALD) is a neuro-metabolic disorder that is caused by malfunction of a peroxisomal transporter protein, adenosine ATP-binding
cassette transporter superfamily D member 1 (ABCD1). We established an induced pluripotent stem cell (iPSC) line from a 42-year-old male X-ALD patient-derived
dermal fibroblasts with Sendai virus-mediated reprogramming. Established iPSCs stably expanded, expressed genes of pluripotency, and maintained normal kar-
yotype. In vitro differentiation assay revealed the characteristics of all three germ layers.
Resource table
Unique stem cell line
identifier
KURNDi007-A
Alternative name(s) of
stem cell line
acALD7
Institution Department of Biotechnology, College of Life Science and
Biotechnology, Korea University
Contact information of
distributor
Dae-Sung Kim, sonnet10@korea.ac.kr
Seungkwon You, bioseung@korea.ac.kr
Type of cell line iPSC
Origin Human
Additional origin info Age: 42
Sex: Male
Ethnicity if known: Asian (Korean)
Cell Source Skin fibroblasts
Clonality Clonal
Method of reprogram-
ming
Sendai virus (Cytotune® 2.0)
Genetic Modification No
Type of Modification N/A
Associated disease X-linked adrenoleukodystrophy (X-ALD)
Gene/locus ABCD1 gene/ Xq28
Method of modification N/A
Name of transgene or
resistance
N/A
Inducible/constitutive
system
N/A
Date archived/stock
date
2017.06.14
Cell line repository/
bank
N/A
Ethical approval Ethical committee: Yonsei University Health System,
Severance Hospital, Institutional Review Board
Approval number: 4–2016-0194
Resource utility
This iPSC line will provide an in vitro system for future studies in
pathophysiology and will contribute to the development of new
therapies for X-ALD.
Resource details
X-linked adrenoleukodystrophy (X-ALD) is an inherited neuro-me-
tabolic disorder caused by mutations in ATP-binding cassette trans-
porter subfamily D member 1 (ABCD1) (Kemp et al., 2016). We gen-
erated an induced pluripotent stem cell (iPSC) line from a 42-year-old
patient diagnosed with adult cerebral type-ALD (acALD) by im-
plementing a commercial reprogramming kit (Cytotune®-iPS 2.0).
These cells (KURNDi007-A) maintained the typical morphology of un-
differentiated iPSCs, and were found positive for alkaline phosphatase
(Fig. 1A). The majority of cells expressed various pluripotency markers
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including OCT4, SOX2, NANOG, and SSEA4 (Fig. 1B–C). Under the in
vitro condition, the cells spontaneously differentiated into all three
germ layers, as examined by immunofluorescence staining with mar-
kers like SOX1 (for ectoderm), SOX17 (for endoderm), and Brachyury
(for mesoderm) (Fig. 1D). Karyotype of the expanded iPSCs displayed
normal (46, XY) characteristics except for a small inversion detected at
p12q13 locus (Fig. 1E, indicated by a red arrow). However, the same
was observed in the donor's fibroblasts (Supplementary Fig. 1, indicated
by a red arrow), indicating that this alteration was not created during
reprogramming nor expansion. Genomic sequencing revealed that the
iPSCs carries 14 bp deletion and 6 bp insertion in exon 4 of ABCD1
(c.1240_1253delGGCTACACAGCCCGinsCCGTCC (Fig. 1E), and STR
analysis showed that the original fibroblasts share identical alleles with
the newly created iPSCs (Supplementary Table 1). No mycoplasma
contamination was detected (Table 1, Fig. 1G, indicated by an arrow
head).
Fig. 1. Characterization of KURNDi007-A iPSC line.
Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography Visual record of the line: normal Fig. 1 panel A
Phenotype Qualitative analysis Positive staining for OCT4, NANOG, SOX2, SSEA4 Fig. 1 panel B
Quantitative analysis Expression of pluripotency markers equivalent or greater than
H9 embryonic stem cells
Fig. 1 panel C
Genotype Karyotype (G-banding) and
resolution
46, XY, inv.(9) (p12q13), Resolution 550 Fig. 1 panel E
Identity Microsatellite PCR (mPCR) OR N/A N/A
STR analysis 18 locus tested. 100% match submitted in archive with
journal
Mutation analysis (IF APPLICABLE) Sequencing Hemizygote mutation Fig. 1 panel F
Southern Blot OR WGS N/A N/A
Microbiology and virology Mycoplasma Mycoplasma testing by PCR. Negative Fig. 1 panel G
Differentiation potential Spontaneous differentiation SOX1, SOX17, Brachyury Fig. 1 panel D
Donor screening (OPTIONAL) HIV 1+2 Hepatitis B, Hepatitis C N/A N/A
Genotype additional info (OPTIONAL) Blood group genotyping N/A N/A
HLA tissue typing N/A N/A
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Materials and methods
Cell culture
The dermal fibroblasts were obtained from a 42-year-old X-ALD
patient at the Severance Biomedical Science Institute, Seoul, Korea
under the guidelines of the Institutional Review Board (Approval No. 4-
2013-0570). The fibroblasts were cultured in growth media (GM;
DMEM supplemented with 15% FBS, 1% penicillin/streptomycin,
2mM L-glutamine) at 37 °C in 5% CO2.
Generation of iPSC
Fibroblasts were seeded on a 6-well plate at the density of 1×105
cells/well a day before reprogramming. CytoTune®-iPS 2.0 Sendai
Reprogramming Kit (Thermo Fisher Scientific) was used to reprogram
the fibroblasts following manufacturer's instruction. After viral infec-
tion, the cells were cultured for another week and then transferred onto
mitotically inactivated STO feeder cells (ATCC). Several iPSC-like co-
lonies were observed in a week afterward. The colonies with the typical
morphology of iPSCs were manually selected and passed onto newly
prepared feeder cells from the third week after viral infection (counted
as passage 1), and then subsequently expanded as a constructed cell line
in media composed of DMEM/F12 supplemented with 20% knockout
serum replacement, 1% penicillin/streptomycin, 1× non-essential
amino acid, 1× beta-mercaptoethanol (Thermo Fisher Scientific), and
10 ng/ml basic fibroblast growth factor (PeproTech) at 37 °C in 5% CO2.
After 10 passages, iPSCs grown with feeder cells have been adapted to
the feeder-free culture medium (StemMACS™ medium, Miltenyi
Biotech) on the coating of Matrigel® (hESC-Qualified, Corning).
In vitro differentiation
iPSC colonies were mechanically detached and cultured as em-
bryoid bodies (EBs) in ultra-low attachment 6 well plates (Corning) in
the EB medium (composed of DMEM/F12, 20% KSR, 1× NEAA, and
0.1 mM beta-mercaptoethanol) supplemented with 5% FBS. At day 7,
EBs were plated on Matrigel-coated coverslips and cultured for addi-
tional 2–3 weeks in the same medium. Then, EB colonies were subjected
to immunostaining for germ layer marker expression, as described
below.
Alkaline phosphatase staining
Alkaline phosphatase activity was detected using the Leukocyte
Alkaline Phosphatase Kit (Sigma-Aldrich) according to a manual pro-
vided by the manufacturer.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) in
phosphate buffered saline (PBS) for 10min, permeabilized with 0.1%
Triton X-100 (Sigma-Aldrich) in PBS for 5min, and then blocked with
2% bovine serum albumin (Bovogen biologicals) in PBS for at least one
hour at room temperature. Then, the cells were incubated with primary
antibodies (Table 2) at 4 °C over-night. After thorough washing with
PBS, the samples were exposed to the secondary antibodies for one hour
at room temperature. The samples were mounted on slide glasses with
VECTASHIELD® DAPI mounting medium (Vector Labs) and observed
under the fluorescent microscope (IX73) (Olympus Corp.) with digital
camera (DP73) (Olympus).
Sequencing analysis of the ABCD1 mutant alleles and Karyotyping
Genomic DNA was isolated from the iPSC lines using a G-spin® Total
DNA Extraction Mini Kit (iNtRon Biotechnology). Mutation sequencing
was performed using acALD7-specific primers (Table 2). Karyotyping
using GTG banding was performed by CANCERROP Corp.
Mycoplasma contamination detection
The absence of mycoplasma contamination was confirmed using a e-
Table 2
Reagents details.
Antibodies used for immunocytochemistry
Antibody Dilution Company Cat # and RRID
Pluripotency markers Rabbit anti-OCT3/4 1:500 Santa Cruz Cat# SC-9081, RRID: AB_2167703
Pluripotency markers Rabbit anti-SOX2 1:500 Millipore Cat# AB5603, RRID: AB_2286686
Pluripotency markers Mouse anti-SSEA4 1:1000 Millipore Cat# MAB4304, RRID: AB_177629
Pluripotency markers Rabbit anti-NANOG 1:500 Abcam Cat# AB21624, RRID: AB_446437
Differentiation markers Goat anti-SOX1 1:200 R&D Cat# AF3369, RRID: AB_2239879
Differentiation markers Goat anti-BRACHYURY 1:200 R&D Cat# AF2085, RRID: AB_2200235
Differentiation markers Goat anti-SOX17 1:200 R&D Cat# AF1924, RRID: AB_355060
Secondary antibodies Alexa Fluor®568 donkey anti-goat IgG (H+L) 1:1000 Thermo Fisher Scientific Cat# A11057, RRID: AB_2534104
Secondary antibodies Alexa Fluor®568 donkey anti-rabbit IgG (H+ L) 1:1000 Thermo Fisher Scientific Cat# A10042, RRID: AB_2534017
Secondary antibodies Alexa Fluor®488 donkey anti-mouse IgG (H+L) 1:1000 Thermo Fisher Scientific Cat# A21202, RRID: AB_141607
Primers
Target Forward/Reverse primer (5′-3′)
Targeted mutation analysis/sequencing ABCD1 ATTGAGCGGATCATGTCGTC/ CATGGAGGTCCCTGAGTGAG
Pluripotency Marker (qPCR) OCT3/4 CCTGAAGCAGAAGAGGATCACC/
AAAGCGGCAGATGGTCGTTTGG
Pluripotency Marker (qPCR) SOX2 TGGACAGTTACGCGCACAT/
CGAGTAGGACATGCTGTAGGT
Pluripotency Marker (qPCR) LIN28 TTGAGGAGCAGGCAGAGTGG/
TGCATTTGGACAGAGCATGG
Pluripotency Marker (qPCR) NANOG CTCCAACATCCTGAACCTCAGC/
CGTCACACCATTGCTATTCTTCG
Housekeeping gene (qPCR) ACTB CACCATTGGCAATGAGCGGTTC/
AGGTCCTTGCGGATGTCCACGT
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Myco™ Mycoplasma PCR Detection kit (iNtRON Biotechnology).
STR analysis
STR analysis was performed by Cosmo Genetech.
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Supplementary data to this article can be found online at https://
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